Diversified Healthcare Trust (NASDAQ:DHC) Stock Price Up 3.6% - Here's Why

Diversified Healthcare Trust (NASDAQ:DHC - Get Free Report) was up 3.6% during trading on Friday . The company traded as high as $2.56 and last traded at $2.56. Approximately 184,455 shares were traded during trading, a decline of 83% from the average daily volume of 1,062,423 shares. The stock had previously closed at $2.47.

Analyst Upgrades and Downgrades

DHC has been the subject of several research reports. B. Riley upped their price target on shares of Diversified Healthcare Trust from $5.00 to $6.00 and gave the stock a "buy" rating in a research report on Monday, August 5th. Royal Bank of Canada increased their target price on Diversified Healthcare Trust from $2.00 to $3.00 and gave the company an "underperform" rating in a research report on Monday, October 14th. JMP Securities reissued a "market perform" rating on shares of Diversified Healthcare Trust in a research report on Wednesday, August 21st. Finally, StockNews.com raised Diversified Healthcare Trust from a "sell" rating to a "hold" rating in a research report on Friday, November 8th.

Diversified Healthcare Trust Stock Performance

The company's fifty day simple moving average is $3.51 and its 200-day simple moving average is $3.13. The company has a quick ratio of 11.57, a current ratio of 11.57 and a debt-to-equity ratio of 1.44.

Diversified Healthcare Trust (NASDAQ:DHC - Get Free Report) last announced its earnings results on Monday, November 4th. The real estate investment trust reported ($0.41) earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.46). The business had revenue of $373.64 million for the quarter, compared to analysts' expectations of $376.80 million. Diversified Healthcare Trust had a negative return on equity of 17.55% and a negative net margin of 26.09%. During the same quarter last year, the firm earned $0.03 earnings per share. Sell-side analysts anticipate that Diversified Healthcare Trust will post 0.05 EPS for the current year.

Diversified Healthcare Trust Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, November 14th. Investors of record on Monday, October 28th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 1.56%. The ex-dividend date of this dividend was Monday, October 28th. Diversified Healthcare Trust's dividend payout ratio (DPR) is presently -2.48%.

Hedge Funds Weigh In On Diversified Healthcare Trust

Several hedge funds have recently made changes to their positions in DHC. Jacobs Levy Equity Management Inc. purchased a new stake in shares of Diversified Healthcare Trust in the 3rd quarter valued at $2,197,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Diversified Healthcare Trust by 51.4% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 271,776 shares of the real estate investment trust's stock worth $1,139,000 after purchasing an additional 92,287 shares during the period. Corsair Capital Management L.P. purchased a new position in shares of Diversified Healthcare Trust during the 3rd quarter valued at about $314,000. Pekin Hardy Strauss Inc. acquired a new position in shares of Diversified Healthcare Trust in the 3rd quarter valued at about $341,000. Finally, Intech Investment Management LLC purchased a new stake in shares of Diversified Healthcare Trust in the third quarter worth about $187,000. 75.98% of the stock is owned by institutional investors and hedge funds.

Diversified Healthcare Trust Company Profile

DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.